Dehkordi, Shiva Kazempour
Sajedi, Sogand
Heshmat, Amirreza
Orr, Miranda E.
Zare, Habil
Funding for this research was provided by:
National Institute on Aging (R01AG068293)
National Institute on Aging (R01AG068293)
National Institute on Aging (R01AG068293)
Alzheimer’s Drug Discovery Foundation (GC-201908-2019443)
National Institute of Neurological Disorders and Stroke (R21NS125171)
National Institute of Neurological Disorders and Stroke (RF1NS112391)
Rainwater Charitable Foundation and US Department of Veterans Affairs (I01BX005717)
Cure Alzheimer’s Fund
Article History
Received: 25 January 2025
Accepted: 8 May 2025
First Online: 1 July 2025
Change Date: 12 August 2025
Change Type: Update
Change Details: In the Author Contributions section of this article, the contribution for S.S. was incomplete. The original text stated that S.S. "conducted differential expression and pathway enrichment analyses, prepared Figs. 2–4". This should have read: S.S. "developed code, conducted differential expression and pathway enrichment analyses, prepared Figs. 2–4." The original article has been corrected.
Change Date: 12 August 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41514-025-00262-9
Competing interests
: Dr. Orr has a patent on detecting and treating conditions associated with neuronal senescence with application number 18/694166.